| Literature DB >> 30304666 |
Roseane Guimarães Ferreira1, Magda Vieira Cardoso2, Karine Maria de Souza Furtado3, Kaio Murilo Monteiro Espíndola4, Ruanderson Pereira Amorim5, Marta Chagas Monteiro6.
Abstract
Aflatoxin B1 (AFB1) is currently the most commonly studied mycotoxin due to its great toxicity, its distribution in a wide variety of foods such as grains and cereals and its involvement in the development of + (hepatocellular carcinoma; HCC). HCC is one of the main types of liver cancer, and has become a serious public health problem, due to its high incidence mainly in Southeast Asia and Africa. Studies show that AFB1 acts in synergy with other risk factors such as hepatitis B and C virus leading to the development of HCC through genetic and epigenetic modifications. The genetic modifications begin in the liver through the biomorphic AFB1, the AFB1-exo-8.9-Epoxy active, which interacts with DNA to form adducts of AFB1-DNA. These adducts induce mutation in codon 249, mediated by a transversion of G-T in the p53 tumor suppressor gene, causing HCC. Thus, this review provides an overview of the evidence for AFB1-induced epigenetic alterations and the potential mechanisms involved in the development of HCC, focusing on a critical analysis of the importance of severe legislation in the detection of aflatoxins.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30304666 DOI: 10.1016/j.trsl.2018.09.001
Source DB: PubMed Journal: Transl Res ISSN: 1878-1810 Impact factor: 7.012